Annovis Bio Pleased by Positive Interim Results from Ongoing Phase II Clinical Trials of ANVS401 (Posiphen) for the Treatment of Alzheimer’s Disease and Parkinson’s Disease

Posiphen (R-phenserine) - Annovis Bio

Jul 30, 2021